GENEVA, June 16 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 Ingelheim am Rhein) filed a patent application (PCT/EP2024/085159) for "NOVEL FORMULATION COMPRISING MYELOID-DERIVED GROWTH FACTOR" on Dec 06, 2024. With publication no. WO/2025/120204, the details related to the patent application was published on Jun 12, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): REED, Jon Michael (VP, IP, Legal Boehringer Ingelheim USA900 Ridgebury RoadRidgefiled, Connecticut 06877-0368), WALTHER, Cornelia (c/o Boehringer Ingelheim International GmbHBinger Strasse 17355218 Ingelheim a...